MedTrace Logo

Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia

NCT01361386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13011

Last updated 2014-06-16

No results posted yet for this study

Summary

The purpose of this study is to describe the short-and long-tern (i.e. up to 2 years following the index event) AMPs in patients hospitalized for an acute coronary syndrome (i.e. STEMI or NSTE-ACS), and to document clinical outcomes, economic aspects and impact on quality of life of these AMPs in a 'real-life' setting.

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

Principal Investigators

  • Guy Yeoman · AstraZeneca

  • Prof. Huo Yong · Peking University 1st Hospital

  • Jayanti Visvanathan · AstraZeneca

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • China
  • India
  • Malaysia
  • Singapore
  • South Korea
  • Thailand
  • Vietnam

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01361386 on ClinicalTrials.gov